FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,460,788 | +135.1% | 1,004,682 | +74.8% | 0.00% | +100.0% |
| Q2 2023 | $1,897,028 | +107137.3% | 574,857 | -7.4% | 0.00% | 0.0% |
| Q1 2023 | $1,769 | -99.6% | 620,559 | +664.3% | 0.00% | – |
| Q2 2022 | $398,000 | -51.9% | 81,197 | +132.0% | 0.00% | – |
| Q1 2022 | $828,000 | -37.2% | 35,000 | -53.0% | 0.00% | -100.0% |
| Q4 2021 | $1,318,000 | -53.1% | 74,475 | -25.3% | 0.00% | -50.0% |
| Q3 2021 | $2,813,000 | -57.1% | 99,707 | -84.1% | 0.00% | -50.0% |
| Q2 2021 | $6,557,000 | -6.5% | 625,635 | +5.1% | 0.00% | -20.0% |
| Q1 2021 | $7,010,000 | +1440.7% | 595,061 | +1431.2% | 0.01% | – |
| Q4 2020 | $455,000 | -47.0% | 38,862 | -17.2% | 0.00% | -100.0% |
| Q2 2020 | $859,000 | -61.1% | 46,947 | -74.6% | 0.00% | -80.0% |
| Q1 2020 | $2,209,000 | +47.2% | 185,019 | +105.2% | 0.01% | +150.0% |
| Q4 2019 | $1,501,000 | -27.3% | 90,181 | -71.0% | 0.00% | -33.3% |
| Q3 2019 | $2,065,000 | – | 311,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |